主题：Virus Contamination Testing and Detection in Biological Products

时间：2020年10月14日 周三 19:30 - 20:30

The webinar will present current testing strategies and validated assay methods to ensure biosafety compliance and outline the application of new methods for example next generation sequencing. The testing strategies and methods outlined during this webinar apply in many instances to biosafety testing and characterisation of a range of biologics for example recombinant proteins, monoclonal antibodies, vaccines and gene therapy vectors and cell therapies. SGS Glasgow is a GMP approved testing facility offering a range of validated methods to test a wide range of cell banks and viral vaccine seeds. 

Margaret Temple has twenty-five years’ experience of client consultation to discuss and recommend biosafety testing strategies to clients in Asia, North America and Europe. Margaret has worked with clients developing a wide range of biologics: vaccines, cell therapies, gene therapies, recombinant proteins and monoclonal antibodies. Margaret started her career with Q-One Biotech in 1995 and was a co-founder of Vitrology (now SGS Glasgow since acquisition in 2012) with colleagues who remain in the senior management team of SGS Glasgow.